GenEdit raises $8.5M for nanoparticle gene therapy delivery

GenEdit Inc. (Berkeley, Calif.) raised $8.5 million in seed funding to develop its polymer nanoparticle platform that enables non-viral delivery of gene therapies. New investors DCVC Bio and SK Holdings led the round; existing investors including Sequoia Capital and Bow Capital also participated

GenEdit was founded by University of California Berkeley researchers Kunwoo Lee and Hyo Min Park and Niren Murthy, a professor of bioengineering...